Independent · Evidence-led · We don't sell peptides
EU / NordicsUpdated weeklyEN

#Melanocortin agonists

PT-141, melanotan family.

Latest from the blog

Explainer

Weight Regain After Stopping GLP-1 Drugs

A 2026 Bayesian meta-analysis maps how quickly body weight returns after stopping semaglutide or tirzepatide and what the trajectory looks like over time.

1 Sept 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

GLP-1 in PCOS: the fertility evidence gaps

A scientific debate in Clinical Nutrition ESPEN spotlights how much the field still does not know about semaglutide, PCOS, and fertility.

1 Sept 2026 · PeptideMethods Editorial Team · 5 min read
Explainer

Tirzepatide powder: what the label says

Forum questions about reconstituting tirzepatide powder reveal a key fact: FDA-approved tirzepatide is supplied ready-to-inject, not as a lyophilized powder.

1 Sept 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Tirzepatide vs care in early T2D at 2 years

A 2-year trial in Annals of Internal Medicine finds tirzepatide reduces HbA1c and weight more than intensified conventional care in early T2D.

1 Sept 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Tirzepatide vs semaglutide: meta-analysis

A 2026 meta-analysis in Clinical Obesity pooled head-to-head and indirect trial data comparing tirzepatide and semaglutide for weight loss.

1 Sept 2026 · PeptideMethods Editorial Team · 4 min read
Explainer

Is CJC-1295/ipamorelin flushing normal?

Facial flushing after CJC-1295 and ipamorelin injections is a known, documented reaction pattern for this peptide class, not an unusual one.

31 Aug 2026 · PeptideMethods Editorial Team · 5 min read